Literature DB >> 2438377

Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio.

J Dillner, H Rabin, N Letvin, W Henle, G Henle, G Klein.   

Abstract

Nuclear DNA-binding proteins were extracted from lymphoblastoid cell lines transformed with Epstein-Barr virus (EBV) or with the related lymphotropic herpesviruses of gorilla (Herpesvirus gorilla), chimpanzee (H. pan), baboon (H. papio) or orang-utan (H. pongo). They were immunoblotted with the sera of all four simian species in comparison with EBV antibody-positive human sera. Eight nuclear proteins were identified, and were designated GONA-1 and GONA-2 for H. gorilla-determined nuclear antigens, PANA-1A, PANA-1B and PANA-2 for H. pan, PONA-2 for H. pongo and HUPNA-1 and HUPNA-2 for H. papio-determined nuclear antigens. One of two tested HUPNA-2-positive baboon sera and one PONA-2-positive orang-utan serum also reacted with EBNA-2 in EBV-transformed cells. A human serum that contained antibodies to all five EBNA proteins cross-reacted only with PANA-2 and PONA-2. Monospecific anti-peptide antibodies against EBNA-2, type A, also reacted with PONA-2, but not with the other simian nuclear antigens. The data provide evidence that EBV-like simian lymphotropic herpesviruses induce EBNA-like nuclear antigens and that EBNA-2 and some simian EBNA-related proteins contain an epitope that has been conserved during the evolution of the EBV family of viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438377     DOI: 10.1099/0022-1317-68-6-1587

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 2.  Simian homologues of Epstein-Barr virus.

Authors:  F Wang; P Rivailler; P Rao; Y Cho
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function.

Authors:  D D Loeb; N S Sung; R L Pesano; C J Sexton; C Hutchison; J S Pagano
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.

Authors:  A Moghaddam; J Koch; B Annis; F Wang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Novel simian homologues of Epstein-Barr virus.

Authors:  Bernhard Ehlers; Andreas Ochs; Fabian Leendertz; Michael Goltz; Christophe Boesch; Kerstin Mätz-Rensing
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.

Authors:  X Tong; R Yalamanchili; S Harada; E Kieff
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides--a rabbit model.

Authors:  P Wutzler; A Meerbach; I Färber; H Wolf; K Scheibner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.

Authors:  M Franken; B Annis; A N Ali; F Wang
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome.

Authors:  H Feichtinger; S L Li; E Kaaya; P Putkonen; K Grünewald; K Weyrer; D Böttiger; I Ernberg; A Linde; G Biberfeld
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.